— Know what they know.
Not Investment Advice
Also trades as: NGLFINE.BO (BSE) · $vol 0M

NGLFINE.NS NSE

NGL Fine-Chem Limited
1W: +1.0% 1M: +10.0% 3M: -8.8% YTD: +31.9% 1Y: +121.2% 3Y: +45.9%
₹2,900.00 ($30.13)
-9.50 (-0.33%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 68 · ₹17.9B mcap · 2M float · 1.07% daily turnover

📊 Key Metrics

TTM
₹5B
Revenue
+36.1% YoY
₹480M
Net Income
+130.4% YoY
₹-683M
Free Cash Flow
-129.3% YoY
37.7%
Gross Margin
11.0%
Op. Margin
9.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE15.7%
ROA9.8%
ROIC10.1%

Valuation

P/E31.3
P/B5.4
EV/EBITDA15.3

Leverage

Debt/Equity0.33
Current Ratio1.84
Interest Cov.15.2x

Quality Scores

Piotroski F4/9
Altman Z5.96
Beneish M-1.51

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms